« FDAAA-a 5 yr safety plan | Main | FDA's Cellular, Tissue and Gene Therapies Advisory Committee meets on HESC-derived therapies »

New York leads in health IT commitment-prescription drugs

March 28, , Governor Paterson announced that $105 million in grants have been awarded to 19 leading community-based health information technology (IT) projects. The grants are central to the state's strategy to ensure that clinical information is in the hands of clinicians and their patients to help guide medical decisions and support the delivery of more coordinated, patient-centered care. Governor Paterson stated that:

Electronic health records will begin to repair our fragmented delivery system by making sure that accurate patient information is quickly available so that we can improve health care quality and efficiency. Electronic health records represent a cornerstone in the transformation of our health care system. They will boost our efforts to improve the delivery of preventative care while maintaining appropriate safeguards to protect patient privacy.

The recipients will build a technical infrastructure that will support health care improvements for all New Yorkers, while ensuring the privacy and security of health information.

One aspect of the New York strategy focuses on Medicaid-reimbursed prescription/preferred drugs:

linking Medicaid data to interoperable electronic health records so that clinicians may electronically receive a patient's Medicaid-reimbursed prescriptions, Medicaid eligibility and recertification period, as well as Medicaid's preferred drugs. This will allow clinicians to prescribe medications electronically and make informed decisions about appropriate and lower-cost therapeutically equivalent medicines at the time the prescription is ordered. It will also provide clinical decision support alerts, such as drug interactions, to improve care and reduce costs.

(1) http://www.state.ny.us/governor/press/press_0328081_print.html

Post a comment

(If you haven't left a comment here before, you may need to be approved by the site owner before your comment will appear. Until then, it won't appear on the entry. Thanks for waiting.)

About

This page contains a single entry from the blog posted on April 2, 2008 9:57 AM.

The previous post in this blog was FDAAA-a 5 yr safety plan .

The next post in this blog is FDA's Cellular, Tissue and Gene Therapies Advisory Committee meets on HESC-derived therapies.

Many more can be found on the main index page or by looking through the archives.